09.02.2016 • News

Croda and NiTech in Surfactants Project

Major speciality chemical manufacturer Croda Europe has signed a two-year deal with UK technology group NiTech Solutions to develop a novel method for the continuous production of a range of surfactants.

The agreement includes the design and build of a modular unit based on NiTech’s patented continuous oscillating baffle reactor technology. The project is worth more than £1 million and also includes the UK’s Centre for Process Innovation and the University of Cambridge’s Institute for Manufacturing.

The collaboration will establish the technical and commercial viability of the NiTech process in Croda’s surfactant applications.

NiTech’s chairman, Paul Hodges, commented: “Companies around the world are grappling with increased competitive pressure in their core markets. This project will demonstrate how a major producer like Croda can dramatically reduce its operating and capital costs, whilst maintaining product quality.”

Continuous processes are usually well suited to integrate with equivalent existing batch manufacturing to provide increased capacity. NiTech said their compact design will often enable this to be achieved without the need for additional supporting infrastructure and extended footprint.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

most read